Order Form “Anytime you get something on the table that generates cost-savings, people perk up” Public drug plan representative “Patients want drug access—effective medicines to Canadians in a timely manner. The role of SEBs will be to provide Canadian patients a range of drugs at a range of ... Read More

Order Form This special report (25 pages) provides an overview of the Canadian pharmaceutical pricing and reimbursement environment. It includes descriptions of the health care system and pharmaceutical market, and then discusses pharmaceutical pricing including the Patented ... Read More

2002 Update Now Available   Download the full 2002 report Under a fully funded, publicly administered, national pharmacare program, government spending on prescribed drugs could increase by as much as $8.1 billion and would result in a dramatic shift in funding from the private sector to the public sector. The study, ... Read More

Abstract OBJECTIVE. This paper compares the prices of top selling generic drugs in Canada with prices for comparable generic products in the United States. METHODS. We examined the prices of 27 top selling (in 2001) generic prescription medicines in Canada that were marketed in both Canada and the United States. The sample ... Read More

Download the full report (66 Kb): Canada's Pharmaceutical Balance of Trade (PDF) The purpose of this study is to develop an economic analysis of the Canadian balance of trade in pharmaceuticals. The study presents historical trends in pharmaceutical trade, makes comparisons with other high technology sectors, and outlines opportunities and ... Read More